NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hepion Pharmaceuticals Inc (STU: 336P)

 
336P Technical Analysis
5
As on 24th May 2023 336P STOCK Price closed @ 9.32 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.15 & Strong Buy for SHORT-TERM with Stoploss of 1.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

336PSTOCK Price

Open 9.32 Change Price %
High 9.32 1 Day 8.85 1882.98
Low 9.32 1 Week 0.00 0.00
Close 9.32 1 Month 8.71 1427.87
Volume N/A 1 Year 7.99 600.75
52 Week High 11.58 | 52 Week Low 0.24
 
STU Germany Most Active Stocks
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
BT81 0.02 %
BT81 0.02 %
TINC 0.01 -1.50%
VODI 0.86 %
VODI 0.86 %
 
STU Germany Top Gainers Stocks
PPK 0.03 36625.00%
PPK 0.03 36625.00%
PPK 0.03 36625.00%
PCBK 10.60 2020.00%
PCBK 10.60 2020.00%
336P 9.32 1882.98%
336P 9.32 1882.98%
YBOC 1.74 1640.00%
YBOC 1.74 1640.00%
WSE 0.02 635.29%
 
STU Germany Top Losers Stocks
OKU 41.40 -99.73%
OKU 41.40 -99.73%
KMK 0.08 -99.46%
KMK 0.08 -99.46%
KMK 0.08 -99.46%
XCD 50.89 -96.92%
XCD 50.89 -96.92%
XCD 50.89 -96.92%
XCD 50.89 -96.92%
RWA 28.60 -96.06%
 
 
336P
Daily Charts
336P
Intraday Charts
Whats New @
Bazaartrend
336P
Free Analysis
 
336P Important Levels Intraday
RESISTANCE9.32
RESISTANCE9.32
RESISTANCE9.32
RESISTANCE9.32
RESISTANCE9.32
RESISTANCE9.32
RESISTANCE9.32
RESISTANCE9.32
 
336P Forecast July 2024
4th UP Forecast10.4
3rd UP Forecast10.05
2nd UP Forecast9.84
1st UP Forecast9.63
1st DOWN Forecast9.01
2nd DOWN Forecast8.8
3rd DOWN Forecast8.59
4th DOWN Forecast8.24
 
336P Weekly Forecast
4th UP Forecast9.55
3rd UP Forecast9.48
2nd UP Forecast9.43
1st UP Forecast9.39
1st DOWN Forecast9.25
2nd DOWN Forecast9.21
3rd DOWN Forecast9.16
4th DOWN Forecast9.09
 
336P Forecast2024
4th UP Forecast31.52
3rd UP Forecast24.4
2nd UP Forecast20
1st UP Forecast15.6
1st DOWN Forecast3.04
2nd DOWN Forecast-1.36
3rd DOWN Forecast-5.76
4th DOWN Forecast-12.88
 
 
336P Other Details
Segment EQ
Market Capital 143058976.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
336P Address
336P
 
336P Latest News
 
Your Comments and Response on Hepion Pharmaceuticals Inc
 
336P Business Profile
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Address: 399 Thornall Street, Edison, NJ, United States, 08837
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service